Tudor Investment Corp’s Trillium Therapeutics Inc. TRIL Stock Holding History

Tudor Investment Corp’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100,454	Closed	-$1.76M	–	3224
2021 Q3	$1.76M	Buy	+100,454	New	+$1.17M	0.03%	800

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Tudor Investment Corp's TRIL Position: Q4 2021 in Review

Tudor Investment Corp sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 100,454 shares — an estimated $1.76M sold.

Tudor Investment Corp first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $1.76M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Tudor Investment Corp reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Tudor Investment Corp sold 100,454 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.76M.
Tudor Investment Corp first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Tudor Investment Corp's Trillium Therapeutics Inc. position peaked at $1.76M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Tudor Investment Corp's 13F filing for Q4 2021, filed 14 Feb 2022.